Nygren, P. (2005) “Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: An Acta Oncologica expert report”, Acta Oncologica, 44(3), pp. 203–217. doi: 10.1080/02841860510029798.